Menu
GeneBe

MICA

MHC class I polypeptide-related sequence A, the group of C1-set domain containing

Basic information

Region (hg38): 6:31399783-31415315

Links

ENSG00000204520NCBI:100507436OMIM:600169HGNC:7090Uniprot:Q29983AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MICA gene.

  • Inborn genetic diseases (10 variants)
  • not specified (6 variants)
  • not provided (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MICA gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
10
clinvar
2
clinvar
3
clinvar
15
nonsense
0
start loss
0
frameshift
3
clinvar
3
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
0
non coding
0
Total 0 0 10 3 6

Variants in MICA

This is a list of pathogenic ClinVar variants found in the MICA region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-31403676-C-T not specified Uncertain significance (Nov 17, 2022)2375512
6-31410552-G-A not specified Uncertain significance (Apr 26, 2023)2568960
6-31410557-C-T not specified Uncertain significance (Jan 07, 2022)2270848
6-31410616-G-C not specified Uncertain significance (Jan 23, 2023)2478205
6-31410644-C-T not specified Uncertain significance (Sep 20, 2023)3126115
6-31410665-A-G not specified Uncertain significance (Dec 09, 2023)3126116
6-31410798-G-A Likely benign (Sep 01, 2023)2656400
6-31411146-T-C not specified Uncertain significance (Feb 08, 2023)2463048
6-31411234-T-C not specified Uncertain significance (Nov 17, 2022)2327136
6-31411297-A-G not specified Uncertain significance (Oct 13, 2023)3126118
6-31411341-G-A Likely benign (Jan 01, 2023)2656401
6-31411342-T-C not specified Uncertain significance (Sep 17, 2021)2344566
6-31412040-T-C not specified Benign (Mar 28, 2016)403084
6-31412063-G-C not specified Benign (Apr 17, 2015)218532
6-31412094-G-T not specified Uncertain significance (Nov 03, 2022)2322279
6-31412130-C-A not specified Uncertain significance (Jan 25, 2023)2479101
6-31412154-G-A not specified Benign (Mar 28, 2016)403085
6-31412195-G-A not specified Uncertain significance (May 03, 2023)2521725
6-31412336-G-A Likely benign (Jan 01, 2023)2656402
6-31412380-TGCTG-T not specified Benign (Mar 28, 2016)403086
6-31412384-G-GCT not specified Benign (Mar 28, 2016)403087
6-31412384-G-GCTGCTGCTGCT not specified Benign (Mar 28, 2016)403088

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MICAprotein_codingprotein_codingENST00000449934 511737
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.004970.970114318071143250.0000306
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8021441740.8290.000008862116
Missense in Polyphen4655.8480.82367773
Synonymous0.6585965.80.8970.00000337607
Loss of Function1.96613.90.4326.42e-7166

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003020.000302
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Seems to have no role in antigen presentation. Acts as a stress-induced self-antigen that is recognized by gamma delta T- cells. Ligand for the KLRK1/NKG2D receptor. Binding to KLRK1 leads to cell lysis. {ECO:0000269|PubMed:10426993, ECO:0000269|PubMed:11224526, ECO:0000269|PubMed:11491531, ECO:0000269|PubMed:11777960, ECO:0000269|PubMed:9497295}.;
Disease
DISEASE: Note=Anti-MICA antibodies and ligand shedding are involved in the progression of monoclonal gammopathy of undetermined significance (MGUS)to multiple myeloma.; DISEASE: Psoriasis 1 (PSORS1) [MIM:177900]: A common, chronic inflammatory disease of the skin with multifactorial etiology. It is characterized by red, scaly plaques usually found on the scalp, elbows and knees. These lesions are caused by abnormal keratinocyte proliferation and infiltration of inflammatory cells into the dermis and epidermis. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Psoriatic arthritis (PSORAS) [MIM:607507]: An inflammatory, seronegative arthritis associated with psoriasis. It is a heterogeneous disorder ranging from a mild, non-destructive disease to a severe, progressive, erosive arthropathy. Five types of psoriatic arthritis have been defined: asymmetrical oligoarthritis characterized by primary involvement of the small joints of the fingers or toes; asymmetrical arthritis which involves the joints of the extremities; symmetrical polyarthritis characterized by a rheumatoid like pattern that can involve hands, wrists, ankles, and feet; arthritis mutilans, which is a rare but deforming and destructive condition; arthritis of the sacroiliac joints and spine (psoriatic spondylitis). {ECO:0000269|PubMed:10323458}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Allograft Rejection;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System (Consensus)

Intolerance Scores

loftool
rvis_EVS
3.71
rvis_percentile_EVS
99.56

Haploinsufficiency Scores

pHI
0.0953
hipred
N
hipred_score
0.148
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.101

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Gene ontology

Biological process
T cell mediated cytotoxicity;immune response to tumor cell;immune response;cellular response to DNA damage stimulus;response to heat;viral process;cytolysis;natural killer cell activation;negative regulation of natural killer cell activation;natural killer cell mediated cytotoxicity;susceptibility to natural killer cell mediated cytotoxicity;defense response to bacterium;negative regulation of natural killer cell mediated cytotoxicity;gamma-delta T cell activation;regulation of immune response;defense response to virus
Cellular component
extracellular space;cytoplasm;plasma membrane;integral component of plasma membrane;external side of plasma membrane;cell surface
Molecular function
protein binding;beta-2-microglobulin binding;natural killer cell lectin-like receptor binding